(Q24675215)

2

0 references

M Calabozo

3

0 references

A Herrero-Beites

4

0 references

G García-Erauskin

5

0 references

E Ruiz-Lucea

Annals of the Rheumatic Diseases

6

0 references

language of work or name

English

0 references

publication date

September 1998

0 references

published in

0 references

volume

57

0 references

issue

9

0 references

page(s)

545-9

0 references

cites work

The management of gout

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Treatment of refractory crystal-associated arthritis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Ten years' experience with benzbromarone in the management of gout and hyperuricaemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Studies of urate crystallisation in relation to gout

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Milestones in the treatment of gout

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Withdrawal of allopurinol in patients with gout

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Alcohol and response to treatment of gout

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Control of crystal-induced arthropathies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Strategies and controversies in the treatment of gout and hyperuricaemia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Toxic hepatitis from cinchophen: report of 3 cases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

The pharmacology of hypouricemic effect of benzbromarone

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Hyperuricemia and gout. Classification, complications and management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Hepatic injury caused by benzbromarone

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Subfulminant hepatitis requiring liver transplantation after benzarone administration

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Severe hepatotoxicity related to benzarone: a report of three cases with two fatalities

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Effect of weight-loss on plasma and urinary levels of uric acid

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Renal excretion of hypoxanthine and xanthine in primary gout

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Preliminary criteria for the classification of the acute arthritis of primary gout

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752740

The prevalence and prophylaxis of gout in England

28 November 2018

1 reference

12 December 2020

An evidence based appraisal of the management of nontophaceous interval gout

1 reference

12 December 2020

Should patients with interval gout be treated with urate lowering drugs?

1 reference

12 December 2020

A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis

1 reference

12 December 2020

Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation

1 reference

12 December 2020

Clinical evaluation of benzbromarone. A new uricosuric drug

1 reference

12 December 2020

Tophaceous gout: a clinical and radiographic assessment

1 reference

12 December 2020

An approach to hyperuricemia and gout

1 reference

12 December 2020

Withdrawal of longterm antihyperuricemic therapy in tophaceous gout

1 reference

12 December 2020

Intermittent control of hyperuricemia in the treatment of gout

1 reference

12 December 2020

The misdiagnosis of gout and hyperuricemia

1 reference

12 December 2020

Reduce serum uric acid levels before withdrawing antihyperuricemic therapy in patients with tophaceous gout

1 reference

12 December 2020

Withdrawal of longterm antihyperuricemic therapy in tophaceous gout

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.57.9.545

1 reference

1 reference

1 reference

PubMed publication ID

9849314

1 reference